ABSCI LLC has a total of 36 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and Israel. Its main competitors in its focus markets biotechnology, foods and drinks and pharmaceuticals are BIOTECNOL SA, RESTORAGEN INC and PANGEN BIOTECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Israel | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Australia | 3 | |
#6 | Canada | 3 | |
#7 | China | 3 | |
#8 | Hong Kong | 2 | |
#9 | Japan | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Fermentation | |
#4 | Enzymes | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mcclain Sean | 24 |
#2 | Valasek Mark | 19 |
#3 | Barish Philip | 12 |
#4 | Minshull Jeremy | 9 |
#5 | Vlasek Mark | 5 |
#6 | Mcclain Seah | 5 |
#7 | Patterson Melissa | 3 |
#8 | Liu Jia | 2 |
#9 | Doerner Amy | 1 |
#10 | Mark Vlasek | 1 |
Publication | Filing date | Title |
---|---|---|
CA3114395A1 | Protein purification methods | |
US2018282405A1 | Cytoplasmic expression system | |
WO2017106583A1 | Cytoplasmic expression system | |
US2015353940A1 | Vectors for use in an inducible coexpression system | |
CN111748510A | Inducible coexpression system |